Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine ELISA Kit (AC3051)
Cat.#: ASET-1640
Specifications
Description Dopamine ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of Dopamine concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Universal Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2047 Mouse CaSR ELISA Kit (AC3458) Quantitative inquiry ASET-1647 Mouse Wnt3a ELISA Kit (AC3058) Quantitative inquiry ASET-1317 Rabbit PEDF ELISA Kit (AC2728) Quantitative inquiry ASET-1713 Human CABP ELISA Kit (AC3124) Quantitative inquiry ASET-1727 Human SorCS1 ELISA Kit (AC3138) Quantitative inquiry ASET-2237 Human ATG3 ELISA Kit (AC3648) Quantitative inquiry ASET-1612 Human Nyctalopin ELISA Kit (AC3023) Quantitative inquiry ASET-2251 Sheep Big Dynorphin ELISA Kit (AC3662) Quantitative inquiry ASET-1148 Human Contactin 1 ELISA Kit (AC2559) Quantitative inquiry ASET-2227 Human PON2 ELISA Kit (AC3638) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket